上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2013年
22期
40-42
,共3页
预防接种%疫苗%不良反应%安全性监测
預防接種%疫苗%不良反應%安全性鑑測
예방접충%역묘%불량반응%안전성감측
vaccination%AEFI%surveillance
目的：了解华泾镇2011-2012年预防接种后不良反应发生情况。方法：根据WHO对AEFI的定义与分类，收集华泾镇2011-2012年AEFI监测和接种率监测数据，进行描述统计。结果：共报告AEFI 65例，发生率为141.70/10万。一般反应57例，占AEFI总病例数的87.69%；异常反应8例，占12.31%。19种疫苗中有13种出现不良反应，其中百白破疫苗的报告发生率最高，为493.33/10万，其次为肺炎疫苗，为369.78/10万。结论：2011-2012年华泾镇AEFI监测系统运转良好，今后需进一步探讨AEFI主动监测模式，提高疫苗安全性监测的敏感性。
目的：瞭解華涇鎮2011-2012年預防接種後不良反應髮生情況。方法：根據WHO對AEFI的定義與分類，收集華涇鎮2011-2012年AEFI鑑測和接種率鑑測數據，進行描述統計。結果：共報告AEFI 65例，髮生率為141.70/10萬。一般反應57例，佔AEFI總病例數的87.69%；異常反應8例，佔12.31%。19種疫苗中有13種齣現不良反應，其中百白破疫苗的報告髮生率最高，為493.33/10萬，其次為肺炎疫苗，為369.78/10萬。結論：2011-2012年華涇鎮AEFI鑑測繫統運轉良好，今後需進一步探討AEFI主動鑑測模式，提高疫苗安全性鑑測的敏感性。
목적：료해화경진2011-2012년예방접충후불량반응발생정황。방법：근거WHO대AEFI적정의여분류，수집화경진2011-2012년AEFI감측화접충솔감측수거，진행묘술통계。결과：공보고AEFI 65례，발생솔위141.70/10만。일반반응57례，점AEFI총병례수적87.69%；이상반응8례，점12.31%。19충역묘중유13충출현불량반응，기중백백파역묘적보고발생솔최고，위493.33/10만，기차위폐염역묘，위369.78/10만。결론：2011-2012년화경진AEFI감측계통운전량호，금후수진일보탐토AEFI주동감측모식，제고역묘안전성감측적민감성。
Objective:To understand the reported adverse events following immunization (AEFI) in Huajing Town of Xuhui District from 2011 to 2012. Methods:The surveillance system of AEFI and surveillance data of immunization rate were collected in Huajing Town from 2011 to 2012 and analyzed with descriptive epidemiological methods and Excell2007. Results:During 2 years, 65 cases of AEFI were reported whose incidence rates were 232.70/105. Fifty-seven cases were general response, accounting for 87.69%, and abnormal reaction had 8 cases, accounting for 12.31%. 13 types of 19 vaccines used appeared adverse reaction among which DPT was in the first rank accounting for 435.29/105, followed by the PCV vaccine whose reported rate was 369.78/105. Conclusion:The AEFI surveillance system is working well in Huajing Town from 2011 to 2012. But it is necessary to explore the model of active surveillance of AEFI and improve the sensitivity of vaccine safety surveillance.
